Q4 revenues -- $333 million, up 3% sequentially, driven by recontracting at higher rates and fewer new units set. Q4 adjusted EBITDA -- $184 million, up 9% year over year, setting a new quarterly ...
Edwards Lifesciences Corporation ( EW) Citi's 2026 Unplugged MedTech and Life Sciences Access Day February 26, 2026 10:15 AM EST Thank you everybody who's come to the Unplugged Conference, and Scott ...
Good afternoon, and welcome to the Fiscal Year 2026 Fourth Quarter Financial Results Conference Call for Dell Technologies Inc. I'd like to inform all participants this call is recorded at the request ...
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of ...
The hit medical drama often showcases cutting edge—and sometimes controversial—technologies that are changing the way doctors ...
During the year ended December 31, 2025, Curaleaf invested $63.4 million in capital expenditures, focused on facility upgrades, automation and selective retail expansion in strategic markets. The ...
Discover how multiple compression affects company valuations as earnings increase without a corresponding rise in stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results